Visible Benefits
They are not the same peptide, and they should not be treated as interchangeable shortcuts
History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
Its an alternative, but not necessarily an upgrade
Bad news: those aggregates won't dissolve, they can cause nasty injection site reactions, and the peptide loses its biological activity
The researchers named it Delta Sleep-Inducing Peptide because of its ability to promote delta wave activity on EEG readings, the signature electrical pattern of deep, restorative sleep